These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

190 related articles for article (PubMed ID: 8312978)

  • 21. Fluoxetine for depression.
    Med Lett Drugs Ther; 1988 Apr; 30(764):45-7. PubMed ID: 3258399
    [No Abstract]   [Full Text] [Related]  

  • 22. Comparative safety of antidepressant agents for children and adolescents regarding suicidal acts.
    Schneeweiss S; Patrick AR; Solomon DH; Dormuth CR; Miller M; Mehta J; Lee JC; Wang PS
    Pediatrics; 2010 May; 125(5):876-88. PubMed ID: 20385637
    [TBL] [Abstract][Full Text] [Related]  

  • 23. 5-HT reuptake inhibitors, tricyclic antidepressants and suicidal behaviour.
    Baldwin D; Bullock T; Montgomery D; Montgomery S
    Int Clin Psychopharmacol; 1991 Dec; 6 Suppl 3():49-55; discussion 55-6. PubMed ID: 1839632
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Fluoxetine and concomitant centrally acting medication use during clinical trials of depression: the absence of an effect related to agitation and suicidal behavior.
    Wernicke JF; Sayler ME; Koke SC; Pearson DK; Tollefson GD
    Depress Anxiety; 1997; 6(1):31-9. PubMed ID: 9394873
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Fluoxetine and suicidal ideation.
    Koizumi H
    J Am Acad Child Adolesc Psychiatry; 1991 Jul; 30(4):695. PubMed ID: 1890110
    [No Abstract]   [Full Text] [Related]  

  • 26. The controversial link between antidepressants and suicidality risks in adults: data from a naturalistic study on a large sample of in-patients with a major depressive episode.
    Seemüller F; Riedel M; Obermeier M; Bauer M; Adli M; Mundt C; Holsboer F; Brieger P; Laux G; Bender W; Heuser I; Zeiler J; Gaebel W; Jäger M; Henkel V; Möller HJ
    Int J Neuropsychopharmacol; 2009 Mar; 12(2):181-9. PubMed ID: 18662490
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Suicidality and Survivability in Schizophrenia.
    Naguy A; Al-Rabaie A
    J Nerv Ment Dis; 2017 Jul; 205(7):585. PubMed ID: 28657961
    [No Abstract]   [Full Text] [Related]  

  • 28. Lack of efficacy of fluoxetine in recurrent brief depression and suicidal attempts.
    Montgomery DB; Roberts A; Green M; Bullock T; Baldwin D; Montgomery SA
    Eur Arch Psychiatry Clin Neurosci; 1994; 244(4):211-5. PubMed ID: 7888419
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Suicidality and fluoxetine revisited.
    Masand P; Dewan M
    J Clin Psychiatry; 1992 Mar; 53(3):102-3. PubMed ID: 1548246
    [No Abstract]   [Full Text] [Related]  

  • 30. Does fluoxetine induce suicidality?
    Brewerton TD
    J Clin Psychiatry; 1991 Nov; 52(11):479-80. PubMed ID: 1744069
    [No Abstract]   [Full Text] [Related]  

  • 31. Reexposure to fluoxetine after serious suicide attempts by three patients: the role of akathisia.
    Rothschild AJ; Locke CA
    J Clin Psychiatry; 1991 Dec; 52(12):491-3. PubMed ID: 1752848
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Fluoxetine and suicidal ideation--a review of the literature.
    Crundwell JK
    Int J Neurosci; 1993 Jan; 68(1-2):73-84. PubMed ID: 8063517
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Suicidality in a placebo-controlled fluoxetine study of body dysmorphic disorder.
    Phillips KA; Kelly MM
    Int Clin Psychopharmacol; 2009 Jan; 24(1):26-8. PubMed ID: 19060721
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Emergence of self-destructive phenomena in children and adolescents during fluoxetine treatment.
    King RA; Riddle MA; Chappell PB; Hardin MT; Anderson GM; Lombroso P; Scahill L
    J Am Acad Child Adolesc Psychiatry; 1991 Mar; 30(2):179-86. PubMed ID: 2016219
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Fluoxetine, placebo, and tricyclic antidepressants in major depression with and without anxious features.
    Tollefson GD; Holman SL; Sayler ME; Potvin JH
    J Clin Psychiatry; 1994 Feb; 55(2):50-9. PubMed ID: 8077155
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Adverse events and treatment discontinuations in fluoxetine clinical trials.
    Pande AC; Sayler ME
    Int Clin Psychopharmacol; 1993; 8(4):267-9. PubMed ID: 8277146
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Fluoxetine and adult suicidality revisited: an updated meta-analysis using expanded data sources from placebo-controlled trials.
    Beasley CM; Ball SG; Nilsson ME; Polzer J; Tauscher-Wisniewski S; Plewes J; Acharya N
    J Clin Psychopharmacol; 2007 Dec; 27(6):682-6. PubMed ID: 18004137
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Fluoxetine in tricyclic refractory major depressive disorder.
    Beasley CM; Sayler ME; Cunningham GE; Weiss AM; Masica DN
    J Affect Disord; 1990 Nov; 20(3):193-200. PubMed ID: 2148340
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Course of psychomotor agitation during pharmacotherapy of depression: analysis from double-blind controlled trials with fluoxetine.
    Tollefson GD; Sayler ME
    Depress Anxiety; 1996-1997; 4(6):294-311. PubMed ID: 9166658
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Predictors of suicidality in depressive spectrum disorders in the general population: results of the Netherlands Mental Health Survey and Incidence Study.
    Spijker J; de Graaf R; Ten Have M; Nolen WA; Speckens A
    Soc Psychiatry Psychiatr Epidemiol; 2010 May; 45(5):513-21. PubMed ID: 19618093
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.